New hope for tough arthritis cases: experimental drug enters human trials
NCT ID NCT07412704
First seen Feb 28, 2026 · Last updated May 24, 2026 · Updated 10 times
Summary
This early-stage study tests a new drug called BMS-986528 in 84 adults with rheumatoid arthritis that hasn't responded to standard treatments. The main goals are to check safety and how the drug moves through the body, while also looking for signs it might reduce disease activity. Participants will receive the drug and be monitored for side effects and arthritis symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTHRITIS, RHEUMATOID are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Local Institution - 0001
Shanghai, Shanghai Municipality, 200127, China
Contact
-
Local Institution - 0006
Beijing, Beijing Municipality, 100091, China
Contact
-
Local Institution - 0007
Nanchang, Jiangxi, 330006, China
Contact
-
Local Institution - 0010
Zhengzhou, Henan, 450000, China
Contact
-
Local Institution - 0017
Roma, 00168, Italy
Contact
-
Local Institution - 0019
Rozzano, Milano, 20089, Italy
Contact
-
Local Institution - 0020
Shanghai, Shanghai Municipality, 200040, China
Contact
-
Local Institution - 0021
Cologne, 50937, Germany
Contact
-
Local Institution - 0022
Berlin, 10117, Germany
Contact
-
Local Institution - 0023
Józefów, Masovian Voivodeship, 05-410, Poland
Contact
-
Local Institution - 0027
Geneva, 1211, Switzerland
Contact
-
Local Institution - 0028
Herne, 44652, Germany
Contact
-
Local Institution - 0037
Bern, 3010, Switzerland
Contact
-
Local Institution - 0039
A Coruña, A Coruña [La Coruña], 15006, Spain
Contact
-
Local Institution - 0040
München, Bavaria, 81377, Germany
Contact
-
Local Institution - 0045
Budapest, 1085, Hungary
Contact
-
Local Institution - 0048
Merksem, Flanders, 2170, Belgium
Contact
-
Local Institution - 0049
Leuven, 3000, Belgium
Contact
-
Local Institution - 0050
Aurora, Colorado, 80045, United States
Contact
-
Local Institution - 0051
DeSoto, Texas, 75115, United States
-
Local Institution - 0055
South Miami, Florida, 33143, United States
Contact
-
Local Institution - 0056
Sendenhorst, North Rhine-Westphalia, 48324, Germany
Contact
-
Local Institution - 0057
San Antonio, Texas, 78229, United States
Contact
-
Local Institution - 0058
Córdoba, Córdoba, 14004, Spain
Contact
-
Local Institution - 0060
Ivano-Frankivsk, Ivano-Frankivsk Oblast, 76008, Ukraine
Contact
-
Local Institution - 0061
Ternopil, 46002, Ukraine
Contact
-
Local Institution - 0062
Kyiv, 02000, Ukraine
Contact
-
Local Institution - 0063
Poltava, Poltava Oblast, 36011, Ukraine
Contact
-
Local Institution - 0064
Kyiv, Kyiv Oblast, 01135, Ukraine
Contact
-
Local Institution - 0065
Potsdam, 14467, Germany
Contact
-
Local Institution - 0066
Portland, Oregon, 97239, United States
Contact
Conditions
Explore the condition pages connected to this study.